First trimester prediction of gestational diabetes mellitus using plasma biomarkers: A case-control study

Paula J. Correa*, Pia Venegas, Yasna Palmeiro, Daniela Albers, Gregory Rice, Jaime Roa, Jorge Cortez, Max Monckeberg, Manuel Schepeler, Eduardo Osorio, Sebastian E. Illanes

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

34 Citas (Scopus)


To evaluate the first trimester maternal biomarkers for early pregnancy prediction of gestational diabetes mellitus (GDM).

The study was a case-control study of healthy women with singleton pregnancies at the first trimester carried out at the Obstetrics and Gynecology Unit, Clinica Davila, Santiago, Chile. After obtaining informed consent, peripheral blood samples of pregnant women under 14 weeks of gestation were collected. At 24–28 weeks of pregnancy, women were classified as GDM (n=16) or controls (n=80) based on the results of a 75-g oral glucose tolerance test (OGTT). In all women, we measured concentrations of fasting blood glucose, insulin, glycated hemoglobin, uric acid, cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), alkaline phosphatase (AP), sex hormone-binding globulin (SHBG), adiponectin, tissue plasminogen activator (t-PA), leptin and placental growth factor (PGF).

The GDM group displayed an increased median concentration of cholesterol (P=0.04), triglycerides (P=0.003), insulin (P=0.003), t-PA (P=0.0088) and homeostatic model assessment (HOMA) (P=0.003) and an increased mean concentration of LDL (P=0.009) when compared to the control group. The receiver operating characteristic (ROC) curve for significant variables achieved an area under the curve (AUC) of 0.870, a sensitivity of 81.4% and a specificity of 80.0%. The OGTT was positive for GDM according to the IADPSG (International Diabetes in Pregnancy Study Group) criteria.

Women who subsequently developed GDM showed higher levels of blood-borne biomarkers during the first trimester, compared to women who did not develop GDM. These data warrant validation in a larger cohort.
Idioma originalInglés
Páginas (desde-hasta)161-168
Número de páginas8
PublicaciónJournal of Perinatal Medicine
EstadoPublicada - 1 feb. 2019

Nota bibliográfica

Publisher Copyright:
© 2019 2019 Walter de Gruyter GmbH, Berlin/Boston.


Profundice en los temas de investigación de 'First trimester prediction of gestational diabetes mellitus using plasma biomarkers: A case-control study'. En conjunto forman una huella única.

Citar esto